/ als Transgenic mouse model
Proof of Concept: From Treadmill to Clinic
“While untreated mice fell off the treadmill, treated mice ran, ran, ran.”
ALS mouse models treated with SELanetx™ preserved motor function and validated immune shifts (M1 → M2) using markers like TNF-α, CD206, and NOS1.
Proof of Concept: ALS Mice Maintain Mobility with SELanetx™
Our SELanetx™ blood-conditioning technology is designed to "flip" a person's body back into a healing state. In a recent study using ALS-infected mice, we compared the motor functions of SELanetx™ treated vs. untreated mice - with visibly stunning results.
Impact of Trial Treatment on Mice
Experiment :
• Mice love treadmills!
• Untreated ALS mice (w/ mutated SOD1 gene) fall off.
• ALS mice (w/ mutated SOD1 gene) treated with SELanetx™ run, run, run.
• Mice love treadmills!
• Untreated ALS mice (w/ mutated SOD1 gene) fall off.
• ALS mice (w/ mutated SOD1 gene) treated with SELanetx™ run, run, run.
Results:
M1-M2 phenotype switch, leading to…
Increased physical ability.
Increased quality of life.
We want this result for humans.
